Download presentation
Presentation is loading. Please wait.
Published byΌλυμπος Ιωάννου Modified over 6 years ago
1
AcoArt I Trial design: Patients with femoropopliteal artery disease were randomized to paclitaxel-coated balloon angioplasty (n = 100) vs. standard peripheral balloon angioplasty (n = 100). Results (p < 0.001) Angiographic late lumen loss at 6 months: 0.05 mm in the drug-coated balloon group vs mm in the uncoated balloon group (p < 0.001) Primary patency at 12 months: 76% with the drug-coated balloon vs. 34% with the uncoated balloon (p < 0.001) Serious adverse events were similar between the treatment groups 1.15 mm Conclusions 0.05 Among patients with femoropopliteal artery disease, paclitaxel-coated balloon angioplasty was superior to noncoated balloon angioplasty Paclitaxel-coated balloon angioplasty improved late lumen loss at 6 months and primary vessel patency at 12 months Drug-coated balloon Uncoated balloon Jia X, et al. JACC Cardiovasc Interv 2016;9:1950-2
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.